Oxford Drug Design, the Oxford-based AI drug discovery company, has announced an important milestone in the development of ...

A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...

HONOLULU — Glovadalen (UCB), an investigational brain-penetrant D1 receptor positive allosteric modulator (D1 PAM), is both safe and effective for patients with advanced Parkinson’s disease (PD), new ...

A new experimental antibiotic can handily knock off one of the world’s most notoriously drug-resistant and deadly bacteria —in lab dishes and mice, at least. It does so with a never-before-seen method ...

Researchers have discovered how drugs can affect various membrane-spanning proteins in addition to their intended target, potentially causing unwanted side effects. The results illuminate one of the ...

For the first time, scientists have captured how new antiviral drugs halt the herpes virus in real time as it tries to ...

The risk of heart-related issues accompanying the use of JAK inhibitors has brought the entire drug class under scrutiny. Last September, the FDA said it will require safety warnings for drugs such as ...